Pages that link to "Q41736662"
Jump to navigation
Jump to search
The following pages link to Ophthalmic drug delivery systems—Recent advances (Q41736662):
Displaying 50 items.
- Topical medication instillation techniques for glaucoma (Q24197532) (← links)
- Biomedical Biopolymers, their Origin and Evolution in Biomedical Sciences: A Systematic Review (Q26779076) (← links)
- Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery (Q26786070) (← links)
- Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives (Q26999057) (← links)
- Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery (Q27007119) (← links)
- Nanomedicine approaches for corneal diseases (Q27022253) (← links)
- The hen's egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: Quantification using Photoshop® and ImageJ (Q28364423) (← links)
- Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes (Q28543935) (← links)
- Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats (Q28546739) (← links)
- Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study (Q28548224) (← links)
- Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes (Q30716734) (← links)
- Development of an ex vivo method for evaluation of precorneal residence of topical ophthalmic formulations (Q33466856) (← links)
- Mini drug pump for ophthalmic use. (Q33623415) (← links)
- A novel TRPM8 agonist relieves dry eye discomfort (Q33837188) (← links)
- Solid lipid nanoparticles for ocular drug delivery (Q34116807) (← links)
- Bioadhesion: new possibilities for drug administration? (Q34207256) (← links)
- Influence of permeant lipophilicity on permeation across human sclera (Q34233208) (← links)
- Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection. (Q34509564) (← links)
- Topical medication instillation techniques for glaucoma. (Q34551634) (← links)
- Ocular preparations: the formulation approach (Q34721415) (← links)
- Novel nanoparticulate gel formulations of steroids for the treatment of macular edema (Q34987327) (← links)
- Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity. (Q35138918) (← links)
- One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study (Q35167647) (← links)
- Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment (Q35590154) (← links)
- A comparative bioavailability study of three conventional eye drops versus a single lyophilisate (Q35590848) (← links)
- Bioavailability of fluorescein from a new drug delivery system in human eyes (Q35591645) (← links)
- The potential of chitosan in ocular drug delivery. (Q35624563) (← links)
- Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer (Q35625854) (← links)
- Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma (Q35691647) (← links)
- Ocular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress (Q35783250) (← links)
- Nanosuspensions in drug delivery (Q35876031) (← links)
- Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration (Q35981514) (← links)
- Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts. (Q36286152) (← links)
- A drug-eluting contact lens (Q36311472) (← links)
- Ion-activated In Situ Gelling Ophthalmic Delivery Systems of Azithromycin (Q36345989) (← links)
- Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease (Q36549331) (← links)
- New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly (Q36850339) (← links)
- Novel approaches to retinal drug delivery (Q36903801) (← links)
- Ocular drug delivery: nanomedicine applications (Q36918036) (← links)
- In situ-forming hydrogels for sustained ophthalmic drug delivery (Q36919001) (← links)
- Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. (Q36939218) (← links)
- New frontiers in nanotechnology for cancer treatment (Q37055372) (← links)
- Recent perspectives in ocular drug delivery (Q37256549) (← links)
- Chitosan nanoparticles for drug delivery to the eye. (Q37416144) (← links)
- Contact lenses for drug delivery. (Q37479362) (← links)
- Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer (Q37584464) (← links)
- New techniques for drug delivery to the posterior eye segment (Q37692245) (← links)
- Molecularly imprinted therapeutic contact lenses (Q37735178) (← links)
- Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs (Q37769529) (← links)
- Advances in using chitosan-based nanoparticles forin vitroandin vivodrug and gene delivery (Q37788222) (← links)